Holen Sie sich die Stockscreener-App
7.45
21.14%
1.30
Handel nachbörslich:
7.03
-0.42
-5.64%
Liminatus Pharma Inc Aktie (LIMN) Neueste Nachrichten
Iris Acquisition, Liminatus Pharma Sign SPAC Merger Deal - marketscreener.com
Iris Acquisition Corp confirms delisting and shareholder vote outcomes - Investing.com
Iris Acquisition Corp announces preliminary proxy statement - Investing.com
Iris Acquisition Corp announces business combination - Investing.com
Iris Acquisition Corp announces business combination with Liminatus Pharma - Investing.com
New company Liminatus Pharma Inc to develop three cancer treatments - Labiotech.eu
Cancer-focused Liminatus sets out to test SPAC waters - Fierce Biotech
Liminatus Pharma and Iris Acquisition Corp to Combine - citybiz
0.84%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):